Evaluation of development-specific targets for antiepileptogenic therapy using rapid kindling.
about
Alterations in sociability and functional brain connectivity caused by early-life seizures are prevented by bumetanide.The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments.Pro-epileptogenic effects of viral-like inflammation in both mature and immature brains.Clinical utility of adjunctive retigabine in partial onset seizures in adults.Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsyMammalian target of rapamycin (mTOR) inhibition: potential for antiseizure, antiepileptogenic, and epileptostatic therapy.The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical use.Novel animal models of pediatric epilepsy.mTOR inhibitors as a new therapeutic option for epilepsy.Inflammation and epilepsy in the developing brain: clinical and experimental evidence.Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII).High-frequency and brief-pulse stimulation pulses terminate cortical electrical stimulation-induced afterdischarges.Anti-ictogenic and antiepileptogenic properties of perampanel in mature and immature rats.Glial source of nitric oxide in epileptogenesis: A target for disease modification in epilepsy.Anti-ictogenic and antiepileptogenic properties of brivaracetam in mature and immature rats.
P2860
Q27308078-07F46213-8196-467B-8A90-50FFA2D662F8Q30576758-E6409322-26A7-41F9-A123-8C2F8B29A7EFQ30831728-9E8D006E-B020-4462-9668-CC3A2C6F6DDBQ35717049-0EC093CF-EE7D-4AAC-8E3C-89C34F776105Q37238455-09BF5491-011B-443C-ADF4-F49158F7C5F3Q37419781-F565EC86-D2E7-4D78-A2E6-4F0E150517F3Q37973453-7F6F568F-65DE-48E4-B2E6-253824AF8308Q37998957-6048C443-9E71-436E-B5F5-6D008CA0AD2CQ38112211-4B33AA22-3E9B-4E27-993A-5208B610AB2AQ38325826-1EAE20BF-91A4-4F55-8E8D-9D8E69A5D52CQ39006241-80D75E7C-AF04-4586-8F14-D03F65E6E288Q41043771-1938D548-42F0-4473-92F5-30A13C353665Q47888996-736C5AF6-E936-45FF-9B4E-FCF5D48D7AB0Q47920504-AB20ED83-EC00-452E-AD4D-8814018219E4Q48258054-157F12D4-BCBE-4AD5-B43F-BD0F66EBB8AA
P2860
Evaluation of development-specific targets for antiepileptogenic therapy using rapid kindling.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Evaluation of development-spec ...... therapy using rapid kindling.
@en
Evaluation of development-spec ...... therapy using rapid kindling.
@nl
type
label
Evaluation of development-spec ...... therapy using rapid kindling.
@en
Evaluation of development-spec ...... therapy using rapid kindling.
@nl
prefLabel
Evaluation of development-spec ...... therapy using rapid kindling.
@en
Evaluation of development-spec ...... therapy using rapid kindling.
@nl
P2093
P2860
P1433
P1476
Evaluation of development-spec ...... therapy using rapid kindling.
@en
P2093
Andréy Mazarati
Eduardo Pineda
Raman Sankar
Young Se Kwon
P2860
P356
10.1111/J.1528-1167.2010.02607.X
P478
51 Suppl 3
P577
2010-07-01T00:00:00Z